|
|
|
Volumn 38 Suppl 1, Issue , 2004, Pages
|
|
New therapeutic options in the treatment of attention deficit/hyperactivity disorder;Nuevas opciones terapeuticas en el tratamiento del trastorno por deficit de atencion/hiperactividad.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ATOMOXETINE;
CENTRAL STIMULANT AGENT;
DOPAMINE;
DOPAMINE UPTAKE INHIBITOR;
METHYLPHENIDATE;
NORADRENALIN;
PROPYLAMINE;
ARTICLE;
ATTENTION DEFICIT DISORDER;
BRAIN;
CLINICAL TRIAL;
HISTOLOGY;
HUMAN;
METABOLISM;
ANTIDEPRESSIVE AGENTS;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BRAIN;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CLINICAL TRIALS;
DOPAMINE;
DOPAMINE UPTAKE INHIBITORS;
HUMANS;
METHYLPHENIDATE;
NOREPINEPHRINE;
PROPYLAMINES;
|
|
EID: 3242806182
PISSN: 02100010
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
